Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

NCT04067336

Conditions
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +20 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UCLA Ronald Reagan Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

NCT01955499

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +21 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

Obinutuzumab, Zanubrutinib, and Lenalidomide Followed Short-Cycle of Obinutuzumab and Cytarabine in Newly Diagnosed Mantle Cell Lymphoma

NCT06504199

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
  • Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details
Active, Not Recruiting

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

NCT03844048

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +31 more
Locations
  • University of Arizona Cancer Center - Tucson /ID# 210548 Tucson, Arizona, United States
  • UCLA Santa Monica Hematology Oncology /ID# 210551 Los Angeles, California, United States
  • Ingalls Memorial Hosp /ID# 210553 Harvey, Illinois, United States
  • Dana-Farber Cancer Institute /ID# 215360 Boston, Massachusetts, United States
View all 56 locations
View Trial Details

Related conditions